Having observed that PD-L1-specific G1 HTLs have ability to kill tumor cells, we further evaluated whether PD-L1241-265-specific CD4+ T-cells exhibit an antitumor effect in vivo setting using an immunodeficient mouse. This evidence concerns the gene CD4 and neoplasm.